Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development

作者: Elias A. El-Habr , Georgia Levidou , Eleni-Andriana Trigka , Joanna Sakalidou , Christina Piperi

DOI: 10.1007/S00428-014-1641-3

关键词:

摘要: … significance of PI3K/AKT/mTOR pathway and its interactions with MAPK, JAK/STAT and Notch … These were correlated with the expression status of components of the PI3K/AKT/mTOR …

参考文章(65)
James A. McCubrey, Linda S. Steelman, William H. Chappell, Stephen L. Abrams, Richard A. Franklin, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Saverio Candido, Grazia Malaponte, Maria C. Mazzarino, Paolo Fagone, Ferdinando Nicoletti, Jörg Bäsecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Michele Milella, Agostino Tafuri, Francesca Chiarini, Camilla Evangelisti, Lucio Cocco, Alberto M. Martelli, Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance Oncotarget. ,vol. 3, pp. 1068- 1111 ,(2012) , 10.18632/ONCOTARGET.659
Mahlon D. Johnson, Mary J. O'Connell, Webster Pilcher, Jay E. Reeder, Fibroblast growth factor receptor-3 expression in meningiomas with stimulation of proliferation by the phosphoinositide 3 kinase-Akt pathway. Journal of Neurosurgery. ,vol. 112, pp. 934- 939 ,(2010) , 10.3171/2009.7.JNS09726
Penelope Korkolopoulou, Georgia Levidou, Elias A El-Habr, Christina Piperi, Christos Adamopoulos, Vassilis Samaras, Efstathios Boviatsis, Irene Thymara, Eleni-Andriana Trigka, Stratigoula Sakellariou, Nikolaos Kavantzas, Efstratios Patsouris, Angelica A Saetta, Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas. Histopathology. ,vol. 61, pp. 293- 305 ,(2012) , 10.1111/J.1365-2559.2012.04236.X
Yoh Dobashi, Shioto Suzuki, Hirochika Matsubara, Maiko Kimura, Shunsuke Endo, Akishi Ooi, Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas Cancer. ,vol. 115, pp. 107- 118 ,(2009) , 10.1002/CNCR.23996
Penelope Korkolopoulou, Georgia Levidou, Eleni-Andriana Trigka, Niki Prekete, Maria Karlou, Irene Thymara, Stratigoula Sakellariou, Paraskevi Fragkou, Dimitrios Isaiadis, Petros Pavlopoulos, Efstratios Patsouris, Angelica A. Saetta, A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma BJU International. ,vol. 110, pp. E1237- E1248 ,(2012) , 10.1111/J.1464-410X.2012.11569.X
Malvyne Rolli-Derkinderen, François Machavoine, Jay M. Baraban, Annabelle Grolleau, Laura Beretta, Michel Dy, ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1. Journal of Biological Chemistry. ,vol. 278, pp. 18859- 18867 ,(2003) , 10.1074/JBC.M211696200
C Le Page, I H Koumakpayi, M Alam-Fahmy, A-M Mes-Masson, F Saad, Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. British Journal of Cancer. ,vol. 94, pp. 1906- 1912 ,(2006) , 10.1038/SJ.BJC.6603184
Marie E Beckner, Raghuram Sampath, Ashley B Flowers, Kristopher Katira, Dwain D'Souza, Shashikant Patil, Raj B Patel, Mary L Nordberg, Anil Nanda, None, Low-Level Amplification of Oncogenes Correlates Inversely with Age for Patients with Nontypical Meningiomas World Neurosurgery. ,vol. 79, pp. 313- 319.e10 ,(2013) , 10.1016/J.WNEU.2011.08.023
Josep Castellvi, Angel Garcia, Federico Rojo, Carmen Ruiz-Marcellan, Antonio Gil, Jose Baselga, Santiago Ramon y Cajal, Phosphorylated 4E binding protein 1: A hallmark of cell signaling that correlates with survival in ovarian cancer Cancer. ,vol. 107, pp. 1801- 1811 ,(2006) , 10.1002/CNCR.22195
S Vicent, J M López-Picazo, G Toledo, M D Lozano, W Torre, C Garcia-Corchón, C Quero, J-C Soria, S Martín-Algarra, R G Manzano, L M Montuenga, ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours British Journal of Cancer. ,vol. 90, pp. 1047- 1052 ,(2004) , 10.1038/SJ.BJC.6601644